MIRABEGRON FORMULATION
The present invention relates to a composition for topical and/or transdermal administration comprising mirabegron or a salt thereof, wherein the composition comprises: a) mirabegron or a salt thereof in a range from ≥ 0.01 wt.-% to ≤ 25 wt.-%; and b) a solvent selected from: - dimethyl sulfoxide (DMSO) in a range from ≥ 5 wt.-% to ≤ 99.99 wt.-%; or - a mixture of dimethyl sulfoxide in a range from ≥ 5 wt.-% to ≤ 97.99 wt.-%, and a further solvent selected from i) a monoalcohol in a range from ≥ 5 wt.-% to ≤ 94.99 wt.-%, or ii) glycerol, a glycol, a polyethylene glycol, a glycol ether, mixtures thereof, or mixtures with a monoalcohol in a range from ≥ 5 wt.-% to ≤ 60 wt.-%, or iii) water in a range from ≥ 2 wt.-% to ≤ 10 wt.-%; wherein the wt.-% are based on a total weight of the composition of 100 wt.-%..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 05. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
KAPPES SEBASTIAN KALJU [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-10-05, Last update posted on www.tib.eu: 2023-10-25, Last updated: 2023-11-03 |
|---|
| Patentnummer: |
WO2023187116 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018341985 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018341985 | ||
| 003 | DE-627 | ||
| 005 | 20231103090328.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231103s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018341985 | ||
| 035 | |a (EPA)WO2023187116 | ||
| 035 | |a (EPA)86053575 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a KAPPES SEBASTIAN KALJU |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MIRABEGRON FORMULATION |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-10-05, Last update posted on www.tib.eu: 2023-10-25, Last updated: 2023-11-03 | ||
| 520 | |a The present invention relates to a composition for topical and/or transdermal administration comprising mirabegron or a salt thereof, wherein the composition comprises: a) mirabegron or a salt thereof in a range from ≥ 0.01 wt.-% to ≤ 25 wt.-%; and b) a solvent selected from: - dimethyl sulfoxide (DMSO) in a range from ≥ 5 wt.-% to ≤ 99.99 wt.-%; or - a mixture of dimethyl sulfoxide in a range from ≥ 5 wt.-% to ≤ 97.99 wt.-%, and a further solvent selected from i) a monoalcohol in a range from ≥ 5 wt.-% to ≤ 94.99 wt.-%, or ii) glycerol, a glycol, a polyethylene glycol, a glycol ether, mixtures thereof, or mixtures with a monoalcohol in a range from ≥ 5 wt.-% to ≤ 60 wt.-%, or iii) water in a range from ≥ 2 wt.-% to ≤ 10 wt.-%; wherein the wt.-% are based on a total weight of the composition of 100 wt.-%. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LAMPRECHT ALF |4 aut | |
| 700 | 0 | |a NIU ZHEMING |4 aut | |
| 700 | 0 | |a PFEIFER ALEXANDER |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 05. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:05 |g month:10 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/86053575/publication/WO2023187116A1?q=WO2023187116 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 05 |c 10 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 05 |c 10 | ||